We are live on ! Find out more
CORZ

Core Scientific, Inc. Common Stock

Delisted

CORZ was delisted on the 30th of December, 2022.

141 hedge funds and large institutions have $105M invested in Core Scientific, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 68 funds opening new positions, 44 increasing their positions, 11 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

990% more call options, than puts

Call options by funds: $15.1M | Put options by funds: $1.38M

300% more repeat investments, than reductions

Existing positions increased: 44 | Existing positions reduced: 11

278% more first-time investments, than exits

New positions opened: 68 | Existing positions closed: 18

55% more funds holding

Funds holding: 91141 (+50)

50% less capital invested

Capital invested by funds: $210M → $105M (-$105M)

Holders
141
Holders Change
+50
Holders Change %
+54.95%
% of All Funds
2.38%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
68
Increased
44
Reduced
11
Closed
18
Calls
$15.1M
Puts
$1.38M
Net Calls
+$13.7M
Net Calls Change
-$12.1M
Name Holding Trade Value Shares
Change
Change in
Stake
Qube Research & Technologies (QRT)
26
Qube Research & Technologies (QRT)
United Kingdom
$594K +$1.83M +398,789 New
Goldman Sachs
27
Goldman Sachs
New York
$473K +$1.04M +226,180 +248%
GAMA
28
Graticule Asia Macro Advisors
New York
$459K +$827K +180,000 +141%
Morgan Stanley
29
Morgan Stanley
New York
$458K +$943K +205,195 +199%
RhumbLine Advisers
30
RhumbLine Advisers
Massachusetts
$453K +$1.4M +304,178 New
Jane Street
31
Jane Street
New York
$388K +$922K +200,598 +335%
FPCP
32
Fort Point Capital Partners
California
$388K +$1.2M +260,294 New
EF
33
Empowered Funds
Pennsylvania
$372K +$266K +57,836 +30%
RDWM
34
Red Door Wealth Management
Tennessee
$332K +$1.03M +223,140 New
JP Morgan Chase
35
JP Morgan Chase
New York
$306K +$937K +203,906 +12,321%
Walleye Capital
36
Walleye Capital
New York
$295K +$910K +198,114 New
Lido Advisors
37
Lido Advisors
California
$290K +$897K +195,291 New
SWA
38
SFMG Wealth Advisors
Texas
$263K -$1.72M -375,200 -68%
Commonwealth Equity Services
39
Commonwealth Equity Services
Massachusetts
$262K -$2.3K -500 -0.3%
MRI
40
Mad River Investors
Massachusetts
$243K +$22.1K +4,800 +3%
New York State Common Retirement Fund
41
New York State Common Retirement Fund
New York
$240K +$719K +156,500 +3,246%
Wellington Management Group
42
Wellington Management Group
Massachusetts
$238K +$245K +53,389 +50%
TCWA
43
Ten Capital Wealth Advisors
Washington
$218K +$673K +146,489 New
SC
44
Sepio Capital
Utah
$195K +$9.19K +2,000 +2%
PCM
45
Penserra Capital Management
California
$189K +$192K +41,683 +49%
MIM
46
MetLife Investment Management
New Jersey
$183K +$564K +122,683 New
Nomura Holdings
47
Nomura Holdings
Japan
$158K +$482K +104,855 New
Deutsche Bank
48
Deutsche Bank
Germany
$154K +$475K +103,470 New
AllianceBernstein
49
AllianceBernstein
Tennessee
$154K +$476K +103,600 New
AIG
50
American International Group
New York
$153K +$471K +102,429 New

CORZ Hedge Fund Activity: Q2 2022 in Review

141 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Core Scientific, Inc. Common Stock (CORZ) for Q2 2022, worth a combined $105M — down 50% from $210M a quarter earlier.

Buyers outnumbered sellers: 68 funds opened new CORZ positions and 18 closed out — a net gain of 50 holders — while 44 added to existing stakes and 11 trimmed.

The largest buyer was BlackRock, adding an estimated $51.8M. The largest seller was Kensico Capital Management, exiting entirely with an estimated $7M sold.

  • 141 institutional investors held Core Scientific, Inc. Common Stock (CORZ) as of Q2 2022, up from 91 in Q1 2022.
  • Funds reported $105M of Core Scientific, Inc. Common Stock stock for Q2 2022, down 50% quarter-over-quarter.
  • 68 funds opened new Core Scientific, Inc. Common Stock positions in Q2 2022 and 18 closed out, a net change of +50 holders.
  • The largest Core Scientific, Inc. Common Stock buyer in Q2 2022 was BlackRock, an estimated $51.8M added.
  • The largest Core Scientific, Inc. Common Stock seller in Q2 2022 was Kensico Capital Management, an estimated $7M sold.

Based on aggregated 13F filings for Q2 2022.